Purchases and Sales Made in Q4 2023 in Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID) during Q4 2023. The information is specifically focused on institutions that hold shares of Ovid Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 21, 2024
Q4 2023
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-5.4K- 39.77% |
$16.1K - $20.4K
|
8.18K
$5.48K
|
|
|
Feb 14, 2024
Q4 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-5.5K- 3.67% |
$16.4K - $20.8K
|
145K
$96.8K
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-6.04K- 7.17% |
$18K - $22.8K
|
78.3K
$52.4K
|
|
|
Feb 06, 2024
Q4 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-8.23K- 4.84% |
$24.5K - $31.1K
|
162K
$108K
|
|
|
Feb 13, 2024
Q4 2023
|
Dcf Advisers, LLC
Greenwich, CT |
SELL
|
- |
-11.7K- 38.45% |
$34.9K - $44.2K
|
18.7K
$12.5K
|
|
|
Feb 14, 2024
Q4 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-19.4K- 4.22% |
$57.7K - $73.2K
|
439K
$294K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-29.6K- 36.63% |
$88.2K - $112K
|
51.2K
$34.3K
|
|
|
Feb 13, 2024
Q4 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-45.4K- 2.67% |
$135K - $171K
|
1.66M
$1.11M
|
|
|
Feb 13, 2024
Q4 2023
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-130K- 2.39% |
$387K - $491K
|
5.32M
$3.56M
|